PRENW
Prenetics Global Limited
NASDAQ · Healthcare · Medical - Diagnostics & Research · HK
$0.01
−9.79%Margins
Gross margin
62.6%
EBITDA margin
-43.9%
EBIT margin
-35.2%
Net margin
-47.4%
FCF margin
-24.0%
-72.7%
Return on equity
-44.0%
Return on assets
-53.6%
Return on invested capital
0.87x
Asset turnover
-$49.4M
Cash from operations
$7.78
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026